Go to Medications | Go to Definition
Lab Results, International
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Lab Primary Key | Clinical Category | Result Name | LOINC Code | LOINC Component | LOINC Property | LOINC Time | LOINC System | LOINC Scale | LOINC Method | LOINC Long Name | Common US Use | Common Intl Use | Also Consider | LOINC Status | External Comments | % Consensus Agreement | PCM Status | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.001 | Coronary_Artery_Disease (CAD) | Labs | LOINC | 267,00 | 1.000.276 | Hematology | Hematocrit | 20570-8 | Hematocrit | VFr | Pt | Bld | Qn | Hematocrit [Volume Fraction] of Blood | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||
1.000.277 | Hematology | Hematocrit | 4544-3 | Hematocrit | VFr | Pt | Bld | Qn | Automated count | Hematocrit [Volume Fraction] of Blood by Automated count | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.285 | Hematology | Hematocrit | 71833-8 | Hematocrit | VFr.DF | Pt | Bld | Qn | Automated count | Hematocrit [Pure volume fraction] of Blood by Automated count | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.281 | Hematology | Hematocrit Arterial | 32354-3 | Hematocrit | VFr | Pt | BldA | Qn | Hematocrit [Volume Fraction] of Arterial blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.286 | Hematology | Hematocrit Arterial | 71832-0 | Hematocrit | VFr.DF | Pt | BldA | Qn | Hematocrit [Pure volume fraction] of Arterial blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.279 | Hematology | Hematocrit by Impedance | 31100-1 | Hematocrit | VFr | Pt | Bld | Qn | Impedance | Hematocrit [Volume Fraction] of Blood by Impedance | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.282 | Hematology | Hematocrit Capillary | 42908-4 | Hematocrit | VFr | Pt | BldC | Qn | Hematocrit [Volume Fraction] of Capillary blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.287 | Hematology | Hematocrit Capillary | 71831-2 | Hematocrit | VFr.DF | Pt | BldC | Qn | Hematocrit [Pure volume fraction] of Capillary blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.278 | Hematology | Hematocrit Estimated | 48703-3 | Hematocrit | VFr | Pt | Bld | Qn | Estimated | Hematocrit [Volume Fraction] of Blood by Estimated | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.283 | Hematology | Hematocrit Mixed Venous | 41655-2 | Hematocrit | VFr | Pt | BldMV | Qn | Hematocrit [Volume Fraction] of Mixed venous blood | X | ACTIVE | 100% | Active | Updated Result Name (PCM) | 101,00 | 1.02 | |||||||||
1.000.288 | Hematology | Hematocrit Mixed Venous | 71830-4 | Hematocrit | VFr.DF | Pt | BldMV | Qn | Hematocrit [Pure volume fraction] of Mixed venous blood | X | ACTIVE | 100% | Active | Updated Result Name (PCM) | 101,00 | 1.02 | |||||||||
1.000.284 | Hematology | Hematocrit Venous | 41654-5 | Hematocrit | VFr | Pt | BldV | Qn | Hematocrit [Volume Fraction] of Venous blood | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.289 | Hematology | Hematocrit Venous | 71829-6 | Hematocrit | VFr.DF | Pt | BldV | Qn | Hematocrit [Pure volume fraction] of Venous blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.280 | Hematology | Spun Hematocrit | 4545-0 | Hematocrit | VFr | Pt | Bld | Qn | Spun | Hematocrit [Volume Fraction] of Blood by Centrifugation | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.258 | Hematology | Deprecated Hemoglobin | 42243-6 | Hemoglobin | MCnc | Pt | Bld | Qn | HPLC | Deprecated Hemoglobin [Mass/volume] in Blood | DEPRECATED | 83% | Active | 101,00 | 1.01 | ||||||||||
1.000.256 | Hematology | Hemoglobin | 718-7 | Hemoglobin | MCnc | Pt | Bld | Qn | Hemoglobin [Mass/volume] in Blood | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.273 | Hematology | Hemoglobin | 59260-0 | Hemoglobin | SCnc | Pt | Bld | Qn | Hemoglobin [Moles/volume] in Blood | X | ACTIVE | 83% | Active | 101,00 | 1.01 | ||||||||||
1.000.260 | Hematology | Hemoglobin Arterial | 30313-1 | Hemoglobin | MCnc | Pt | BldA | Qn | Hemoglobin [Mass/volume] in Arterial blood | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.274 | Hematology | Hemoglobin Arterial | 75928-2 | Hemoglobin | SCnc | Pt | BldA | Qn | Hemoglobin [Moles/volume] in Arterial blood | X | ACTIVE | 83% | Active | 101,00 | 1.01 | ||||||||||
1.000.261 | Hematology | Hemoglobin Arterial by Oximetry | 14775-1 | Hemoglobin | MCnc | Pt | BldA | Qn | Oximetry | Hemoglobin [Mass/volume] in Arterial blood by Oximetry | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | ||||||||
1.000.259 | Hematology | Hemoglobin by Oximetry | 55782-7 | Hemoglobin | MCnc | Pt | Bld | Qn | Oximetry | Hemoglobin [Mass/volume] in Blood by Oximetry | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.257 | Hematology | Hemoglobin Calculated | 20509-6 | Hemoglobin | MCnc | Pt | Bld | Qn | Calculated | Hemoglobin [Mass/volume] in Blood by calculation | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | ||||||||
1.000.262 | Hematology | Hemoglobin Capillary | 30352-9 | Hemoglobin | MCnc | Pt | BldC | Qn | Hemoglobin [Mass/volume] in Capillary blood | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.268 | Hematology | Hemoglobin Mixed Venous | 30351-1 | Hemoglobin | MCnc | Pt | BldMV | Qn | Hemoglobin [Mass/volume] in Mixed venous blood | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.269 | Hematology | Hemoglobin Mixed Venous by Oximetry | 76768-1 | Hemoglobin | MCnc | Pt | BldMV | Qn | Oximetry | Hemoglobin [Mass/volume] in Mixed venous blood by Oximetry | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.272 | Hematology | Hemoglobin Qual | 717-9 | Hemoglobin | PrThr | Pt | Bld | Ord | Hemoglobin [Presence] in Blood | X | ACTIVE | 83% | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.270 | Hematology | Hemoglobin Venous | 30350-3 | Hemoglobin | MCnc | Pt | BldV | Qn | Hemoglobin [Mass/volume] in Venous blood | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.275 | Hematology | Hemoglobin Venous | 93846-4 | Hemoglobin | SCnc | Pt | BldV | Qn | Hemoglobin [Moles/volume] in Venous blood | X | ACTIVE | 83% | Active | 101,00 | 1.01 | ||||||||||
1.000.271 | Hematology | Hemoglobin Venous by Oximetry | 76769-9 | Hemoglobin | MCnc | Pt | BldV | Qn | Oximetry | Hemoglobin [Mass/volume] in Venous blood by Oximetry | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.293 | Hematology | Deprecated Platelet Count | 5907-1 | Platelets | NCnc | Pt | Bld | Qn | Automated count | Deprecated Platelets [#/volume] in Blood by Automated count | DEPRECATED | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.291 | Hematology | Platelet Count | 26515-7 | Platelets | NCnc | Pt | Bld | Qn | Platelets [#/volume] in Blood | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.292 | Hematology | Platelet Count | 777-3 | Platelets | NCnc | Pt | Bld | Qn | Automated count | Platelets [#/volume] in Blood by Automated count | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.294 | Hematology | Platelet Estimate | 49497-1 | Platelets | NCnc | Pt | Bld | Qn | Estimate | Platelets [#/volume] in Blood by Estimate | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.295 | Hematology | Platelet Manual | 778-1 | Platelets | NCnc | Pt | Bld | Qn | Manual count | Platelets [#/volume] in Blood by Manual count | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.290 | Hematology | Platelets by Microscopy | 79427-1 | Platelets | Naric | Pt | Bld | Qn | Microscopy.light.HPF | Platelets [#/area] in Blood by Microscopy high power field | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.296 | Hematology | Platelets Capillary Manual | 74464-9 | Platelets | NCnc | Pt | BldC | Qn | Manual count | Platelets [#/volume] in Capillary blood by Manual count | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.303 | Coagulation Tests | Deprecated INR | 5895-7 | Coagulation tissue factor induced.INR | TRto | Pt | Plas | Qn | Coag | Deprecated INR in Platelet poor plasma by Coagulation assay | DEPRECATED | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.301 | Coagulation Tests | INR | 6301-6 | Coagulation tissue factor induced.INR | RelTime | Pt | PPP | Qn | Coag | INR in Platelet poor plasma by Coagulation assay | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | ||||||||
1.000.302 | Coagulation Tests | INR | 38875-1 | Coagulation tissue factor induced.INR | RelTime | Pt | PPP/Bld | Qn | Coag | INR in Platelet poor plasma or blood by Coagulation assay | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.299 | Coagulation Tests | INR (Point of Care) | 34714-6 | Coagulation tissue factor induced.INR | RelTime | Pt | Bld | Qn | Coag | INR in Blood by Coagulation assay | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | ||||||||
1.000.300 | Coagulation Tests | INR (Point of Care) Capillary | 46418-0 | Coagulation tissue factor induced.INR | RelTime | Pt | BldC | Qn | Coag | INR in Capillary blood by Coagulation assay | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.179 | Kidney Function Tests | Creatinine | 2160-0 | Creatinine | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.181 | Kidney Function Tests | Creatinine | 14682-9 | Creatinine | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.254 | Kidney Function Tests | Creatinine Arterial | 21232-4 | Creatinine | MCnc | Pt | BldA | Qn | Creatinine [Mass/volume] in Arterial blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.253 | Kidney Function Tests | Creatinine Blood | 38483-4 | Creatinine | MCnc | Pt | Bld | Qn | Creatinine [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.255 | Kidney Function Tests | Creatinine Blood | 59826-8 | Creatinine | SCnc | Pt | Bld | Qn | Creatinine [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.180 | Kidney Function Tests | Creatinine Max during Study | 44784-7 | Creatinine | MCnc | Stdy^max | Ser/Plas | Qn | Creatinine [Mass/volume] (Maximum value during study) in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.182 | Kidney Function Tests | Creatinine Serum Plasma or Blood | 77140-2 | Creatinine | SCnc | Pt | Ser/Plas/Bld | Qn | Creatinine [Moles/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.250 | Kidney Function Tests | Creatinine Pre Contrast | 72271-0 | Creatinine^pre contrast | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --pre contrast | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | ||||||||||
1.000.251 | Kidney Function Tests | Creatinine Pre Dialysis | 11042-9 | Creatinine^pre dialysis | MCnc | Pt | Ser/Plas | Qn | Creatinine [Mass/volume] in Serum or Plasma --pre dialysis | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | ||||||||||
1.000.252 | Kidney Function Tests | Creatinine Pre Dialysis | 51619-5 | Creatinine^pre dialysis | SCnc | Pt | Ser/Plas | Qn | Creatinine [Moles/volume] in Serum or Plasma --pre dialysis | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | ||||||||||
1.000.011 | Kidney Function Tests | Deprecated eGFR by Schwartz | 50383-9 | Glomerular filtration rate.predicted | VRat | Pt | Ser/Plas | Qn | Creatinine-based formula (Schwartz) | Deprecated Glomerular filtration rate/1.73 sq M.predicted in 24 hour by Creatinine-based formula (Schwartz) | DEPRECATED | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.000 | Kidney Function Tests | eGFR | 69405-9 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.004 | Kidney Function Tests | eGFR Blood by MDRD (Discouraged) | 76633-7 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted by Creatinine-based formula (MDRD) in Blood | DISCOURAGED | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.001 | Kidney Function Tests | eGFR by CKD-EPI | 62238-1 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (CKD-EPI) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.013 | Kidney Function Tests | eGFR by Cystatin | 50210-4 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Cystatin-based formula | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin-based formula | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.006 | Kidney Function Tests | eGFR by MDRD | 77147-7 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.005 | Kidney Function Tests | eGFR by MDRD (Discouraged) | 33914-3 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) | DISCOURAGED | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.012 | Kidney Function Tests | eGFR by Schwartz | 50384-7 | Glomerular filtration rate/1.73 sq M.predicted | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (Schwartz) | Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (Schwartz) | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.002 | Kidney Function Tests | eGFR by CKD-EPI in blacks | 88293-6 | Glomerular filtration rate/1.73 sq M.predicted.black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (CKD-EPI) | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.007 | Kidney Function Tests | eGFR by MDRD in blacks | 48643-1 | Glomerular filtration rate/1.73 sq M.predicted.black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.008 | Kidney Function Tests | eGFR by MDRD in females | 50044-7 | Glomerular filtration rate/1.73 sq M.predicted.female | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among females [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.009 | Kidney Function Tests | eGFR by MDRD in males | 70969-1 | Glomerular filtration rate/1.73 sq M.predicted.male | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among males [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.003 | Kidney Function Tests | eGFR by CKD-EPI in non-blacks | 88294-4 | Glomerular filtration rate/1.73 sq M.predicted.non black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (CKD-EPI) | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI) | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.010 | Kidney Function Tests | eGFR by MDRD in non-blacks | 48642-3 | Glomerular filtration rate/1.73 sq M.predicted.non black | ArVRat | Pt | Ser/Plas/Bld | Qn | Creatinine-based formula (MDRD) | Glomerular filtration rate/1.73 sq M.predicted among non-blacks [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD) | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.152 | Kidney Function Tests | BUN | 3094-0 | Urea nitrogen | MCnc | Pt | Ser/Plas | Qn | Urea nitrogen [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.153 | Kidney Function Tests | BUN | 14937-7 | Urea nitrogen | SCnc | Pt | Ser/Plas | Qn | Urea nitrogen [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.162 | Kidney Function Tests | BUN Blood | 6299-2 | Urea nitrogen | MCnc | Pt | Bld | Qn | Urea nitrogen [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.166 | Kidney Function Tests | BUN Blood | 59570-2 | Urea nitrogen | SCnc | Pt | Bld | Qn | Urea nitrogen [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.167 | Kidney Function Tests | BUN Baseline | 12964-3 | Urea nitrogen^baseline | MCnc | Pt | Bld | Qn | Urea nitrogen [Mass/volume] in Blood --baseline | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | ||||||||||
1.000.160 | Kidney Function Tests | BUN Pre Contrast | 72270-2 | Urea nitrogen^pre contrast | MCnc | Pt | Ser/Plas | Qn | Urea nitrogen [Mass/volume] in Serum or Plasma --pre contrast | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | ||||||||||
1.000.161 | Kidney Function Tests | BUN Pre Dialysis | 11065-0 | Urea nitrogen^pre dialysis | MCnc | Pt | Ser/Plas | Qn | Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | ||||||||||
1.000.425 | Liver Function Tests | ALT (SGPT) | 1742-6 | Alanine aminotransferase | CCnc | Pt | Ser/Plas | Qn | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | X | X | ACTIVE | 67% | Active | 101,00 | 1.01 | |||||||||
1.000.423 | Liver Function Tests | ALT (SGPT) Blood | 76625-3 | Alanine aminotransferase | CCnc | Pt | Bld | Qn | Alanine aminotransferase [Enzymatic activity/volume] in Blood | X | ACTIVE | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.427 | Liver Function Tests | ALT (SGPT) by P5'P | 1743-4 | Alanine aminotransferase | CCnc | Pt | Ser/Plas | Qn | With P-5'-P | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P | X | ACTIVE | 67% | Active | 101,00 | 1.01 | |||||||||
1.000.428 | Liver Function Tests | ALT (SGPT) Serum, Plasma or Blood | 77144-4 | Alanine aminotransferase | CCnc | Pt | Ser/Plas/Bld | Qn | Alanine aminotransferase [Enzymatic activity/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.426 | Liver Function Tests | ALT (SGPT) Without P5'P | 1744-2 | Alanine aminotransferase | CCnc | Pt | Ser/Plas | Qn | No addition of P-5'-P | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by No addition of P-5'-P | X | X | ACTIVE | 67% | Active | 101,00 | 1.01 | ||||||||
1.000.429 | Liver Function Tests | ALT (SGPT) Without P5'P Max during Study | 44785-4 | Alanine aminotransferase | CCnc | Stdy^max | Ser/Plas | Qn | No addition of P-5'-P | Alanine aminotransferase [Enzymatic activity/volume] (Maximum value during study) in Serum or Plasma by No addition of P-5'-P | X | ACTIVE | 67% | Active | 101,00 | 1.01 | |||||||||
1.000.306 | Lipids | Deprecated Total Cholesterol | 2565-0 | Cholesterol | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 101,00 | 1.01 | |||||||||||
1.000.311 | Lipids | Deprecated Total Cholesterol Blood | 50339-1 | Cholesterol | MCnc | Pt | Bld | Qn | Deprecated Cholesterol [Mass/volume] in blood | DEPRECATED | 100% | Active | 101,00 | 1.01 | |||||||||||
1.000.307 | Lipids | Total Cholesterol | 2093-3 | Cholesterol | MCnc | Pt | Ser/Plas | Qn | Cholesterol [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.309 | Lipids | Total Cholesterol | 9342-7 | Cholesterol | Prctl | Pt | Ser/Plas | Qn | Cholesterol [Percentile] | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.310 | Lipids | Total Cholesterol | 14647-2 | Cholesterol | SCnc | Pt | Ser/Plas | Qn | Cholesterol [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.312 | Lipids | Total Cholesterol Blood Qual by Test Strip | 5932-9 | Cholesterol | PrThr | Pt | Bld | Ord | Test strip | Cholesterol [Presence] in Blood by Test strip | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | ||||||||
1.000.308 | Lipids | Total Cholesterol Ultracentrifuged | 48620-9 | Cholesterol | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.327 | Lipids | Deprecated HDL Cholesterol | 2086-7 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol.in HDL [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 101,00 | 1.01 | |||||||||||
1.000.328 | Lipids | HDL Cholesterol | 2085-9 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol in HDL [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.333 | Lipids | HDL Cholesterol | 14646-4 | Cholesterol.in HDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol in HDL [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.326 | Lipids | HDL Cholesterol by Electrophoresis | 12772-0 | Cholesterol.in HDL | ACnc | Pt | Ser/Plas | Qn | Electrophoresis | Cholesterol in HDL [Units/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | ||||||||
1.000.329 | Lipids | HDL Cholesterol by Electrophoresis | 49130-8 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas | Qn | Electrophoresis | Cholesterol in HDL [Mass/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | ||||||||
1.000.331 | Lipids | HDL Cholesterol Qual | 27340-9 | Cholesterol.in HDL | PrThr | Pt | Ser/Plas | Ord | Cholesterol in HDL [Presence] in Serum or Plasma | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.332 | Lipids | HDL Cholesterol Qual by Electrophoresis | 12771-2 | Cholesterol.in HDL | PrThr | Pt | Ser/Plas | Ord | Electrophoresis | Cholesterol in HDL [Presence] in Serum or Plasma by Electrophoresis | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | ||||||||
1.000.330 | Lipids | HDL Cholesterol Ultracentrifuged | 18263-4 | Cholesterol.in HDL | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.314 | Lipids | Deprecated LDL Cholesterol | 2090-9 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol.in LDL [Mass/volume] in Serum or Plasma | DEPRECATED | 100% | Active | 101,00 | 1.01 | |||||||||||
1.000.316 | Lipids | LDL Calculated | 13457-7 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.323 | Lipids | LDL Calculated | 39469-2 | Cholesterol.in LDL | SCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.315 | Lipids | LDL Cholesterol | 2089-1 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol in LDL [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.321 | Lipids | LDL Cholesterol | 14155-6 | Cholesterol.in LDL | Prctl | Pt | Ser/Plas | Qn | Cholesterol in LDL [Percentile] | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.322 | Lipids | LDL Cholesterol | 22748-8 | Cholesterol.in LDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol in LDL [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.313 | Lipids | LDL Cholesterol by Electrophoresis | 12773-8 | Cholesterol.in LDL | ACnc | Pt | Ser/Plas | Qn | Electrophoresis | Cholesterol in LDL [Units/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | ||||||||
1.000.318 | Lipids | LDL Cholesterol by Electrophoresis | 49132-4 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Electrophoresis | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | ||||||||
1.000.319 | Lipids | LDL Cholesterol by VAP | 55440-2 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | VAP | Cholesterol.in LDL (real) [Mass/volume] in Serum or Plasma by VAP | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.317 | Lipids | LDL Cholesterol Direct Assay | 18262-6 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas | Qn | Direct assay | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.324 | Lipids | LDL Cholesterol Direct Assay | 69419-0 | Cholesterol.in LDL | SCnc | Pt | Ser/Plas | Qn | Direct assay | Cholesterol in LDL [Moles/volume] in Serum or Plasma by Direct assay | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.320 | Lipids | LDL Cholesterol Ultracentrifuged | 18261-8 | Cholesterol.in LDL | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.355 | Lipids | Deprecated VLDL | 2092-5 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas | Qn | Deprecated Cholesterol.in VLDL [Mass/volume] in Serum or Plasma | DEPRECATED | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||||
1.000.356 | Lipids | VLDL | 2091-7 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol in VLDL [Mass/volume] in Serum or Plasma | X | ACTIVE | Inactive | Item Inactivated | 101,00 | 1.02 | ||||||||||
1.000.360 | Lipids | VLDL | 25371-6 | Cholesterol.in VLDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol in VLDL [Moles/volume] in Serum or Plasma | X | ACTIVE | Inactive | Item Inactivated | 101,00 | 1.02 | ||||||||||
1.000.358 | Lipids | VLDL by Electrophoresis | 49133-2 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas | Qn | Electrophoresis | Cholesterol in VLDL [Mass/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.357 | Lipids | VLDL Calculated | 13458-5 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation | X | ACTIVE | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.361 | Lipids | VLDL Calculated | 66126-4 | Cholesterol.in VLDL | SCnc | Pt | Ser/Plas | Qn | Calculated | Cholesterol in VLDL [Moles/volume] in Serum or Plasma by calculation | X | ACTIVE | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.359 | Lipids | VLDL Ultracentrifuged | 48618-3 | Cholesterol.in VLDL | MCnc | Pt | Ser/Plas.ultracentrifugate | Qn | Cholesterol in VLDL [Mass/volume] in Serum or Plasma ultracentrifugate | X | ACTIVE | Inactive | Item Inactivated | 101,00 | 1.02 | ||||||||||
1.000.352 | Lipids | Non-HDL Cholesterol | 43396-1 | Cholesterol.non HDL | MCnc | Pt | Ser/Plas | Qn | Cholesterol non HDL [Mass/volume] in Serum or Plasma | X | ACTIVE | Active | 101,00 | 1.01 | |||||||||||
1.000.353 | Lipids | Non-HDL Cholesterol | 70204-3 | Cholesterol.non HDL | SCnc | Pt | Ser/Plas | Qn | Cholesterol non HDL [Moles/volume] in Serum or Plasma | X | ACTIVE | Active | 101,00 | 1.01 | |||||||||||
1.000.339 | Lipids | Triglycerides | 2571-8 | Triglyceride | MCnc | Pt | Ser/Plas | Qn | Triglyceride [Mass/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.341 | Lipids | Triglycerides | 30570-6 | Triglyceride | Prctl | Pt | Ser/Plas | Qn | Triglyceride [Percentile] | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.343 | Lipids | Triglycerides | 14927-8 | Triglyceride | SCnc | Pt | Ser/Plas | Qn | Triglyceride [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.349 | Lipids | Triglycerides Blood | 3043-7 | Triglyceride | MCnc | Pt | Bld | Qn | Triglyceride [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.350 | Lipids | Triglycerides Blood | 70218-3 | Triglyceride | SCnc | Pt | Bld | Qn | Triglyceride [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.340 | Lipids | Triglycerides Calculated | 12951-0 | Triglyceride | MCnc | Pt | Ser/Plas | Qn | Calculated | Triglyceride [Mass/volume] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.342 | Lipids | Triglycerides Qual | 28554-4 | Triglyceride | PrThr | Pt | Ser/Plas | Ord | Triglyceride [Presence] in Serum or Plasma | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.344 | Lipids | Triglycerides 12 Hours Fasting | 1644-4 | Triglyceride^post 12H CFst | MCnc | Pt | Ser/Plas | Qn | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.345 | Lipids | Triglycerides 12 Hours Fasting | 30524-3 | Triglyceride^post 12H CFst | SCnc | Pt | Ser/Plas | Qn | Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.346 | Lipids | Deprecated Triglycerides Fasting | 17081-1 | Triglyceride^post CFst | MCnc | Pt | Ser | Qn | Deprecated Triglyceride [Mass/volume] in Serum or Plasma --post CFst | DEPRECATED | 100% | Active | 101,00 | 1.01 | |||||||||||
1.000.347 | Lipids | Triglycerides Fasting | 3048-6 | Triglyceride^post CFst | MCnc | Pt | Ser/Plas | Qn | Triglyceride [Mass/volume] in Serum or Plasma --fasting | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.348 | Lipids | Triglycerides Fasting | 47210-0 | Triglyceride^post CFst | SCnc | Pt | Ser/Plas | Qn | Triglyceride [Moles/volume] in Serum or Plasma --fasting | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.414 | Cardiac Tests | CRP Blood High Sensitivity | 71426-1 | C reactive protein | MCnc | Pt | Bld | Qn | High sensitivity | C reactive protein [Mass/volume] in Blood by High sensitivity method | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.417 | Cardiac Tests | CRP High Sensitivity | 30522-7 | C reactive protein | MCnc | Pt | Ser/Plas | Qn | High sensitivity | C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method | X | X | ACTIVE | 83% | Active | 101,00 | 1.01 | ||||||||
1.000.419 | Cardiac Tests | CRP High Sensitivity | 35648-5 | C reactive protein | Quintile | Pt | Ser/Plas | Qn | High sensitivity | C reactive protein [Quintile] in Serum or Plasma by High sensitivity method | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.421 | Cardiac Tests | CRP High Sensitivity | 76486-0 | C reactive protein | SCnc | Pt | Ser/Plas | Qn | High sensitivity | C reactive protein [Moles/volume] in Serum or Plasma by High sensitivity method | X | ACTIVE | 83% | Active | 101,00 | 1.01 | |||||||||
1.000.368 | Cardiac Tests | CKMB | 32673-6 | Creatine kinase.MB | CCnc | Pt | Ser/Plas | Qn | Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.382 | Cardiac Tests | CKMB Blood | 49551-5 | Creatine kinase.MB | MCnc | Pt | Bld | Qn | Creatine kinase.MB [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.370 | Cardiac Tests | CKMB by Electrophoresis | 2154-3 | Creatine kinase.MB | CCnc | Pt | Ser/Plas | Qn | Electrophoresis | Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.373 | Cardiac Tests | CKMB Qual | 38482-6 | Creatine kinase.MB | PrThr | Pt | Ser/Plas | Ord | Creatine kinase.MB [Presence] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.369 | Cardiac Tests | Deprecated CKMB | 6773-6 | Creatine kinase.MB | CCnc | Pt | Ser/Plas | Qn | EIA | Deprecated Creatine kinase.MB | DEPRECATED | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.371 | Cardiac Tests | CKMB | 13969-1 | Creatine kinase.MB | MCnc | Pt | Ser/Plas | Qn | Creatine kinase.MB [Mass/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | |||||||||
1.000.372 | Cardiac Tests | CKMB by Immunoassay | 83092-7 | Creatine kinase.MB | MCnc | Pt | Ser/Plas | Qn | IA | Creatine kinase.MB [Mass/volume] in Serum or Plasma by Immunoassay | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | |||||||||
1.000.374 | Cardiac Tests | CKMB % | 20569-0 | Creatine kinase.MB/Creatine kinase.total | CFr | Pt | Ser/Plas | Qn | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma | X | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | |||||||||
1.000.375 | Cardiac Tests | CKMB % Calculated | 12189-7 | Creatine kinase.MB/Creatine kinase.total | CFr | Pt | Ser/Plas | Qn | Calculated | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by calculation | X | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | ||||||||
1.000.376 | Cardiac Tests | Deprecated CKMB % | 12188-9 | Creatine kinase.MB/Creatine kinase.total | CFr | Pt | Ser/Plas | Qn | EIA | Deprecated Creatine kinase.MB/Creatine kinase.total | DEPRECATED | 100% | Active | New item (PCM) | 102,00 | ||||||||||
1.000.377 | Cardiac Tests | CKMB % by Electrophoresis | 12187-1 | Creatine kinase.MB/Creatine kinase.total | CFr | Pt | Ser/Plas | Qn | Electrophoresis | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | |||||||||
1.000.378 | Cardiac Tests | CKMB % Calculated | 72564-8 | Creatine kinase.MB/Creatine kinase.total | CFr.DF | Pt | Ser/Plas | Qn | Calculated | Creatine kinase.MB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by calculation | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | |||||||||
1.000.379 | Cardiac Tests | CKMB % by Electrophoresis | 72563-0 | Creatine kinase.MB/Creatine kinase.total | CFr.DF | Pt | Ser/Plas | Qn | Electrophoresis | Creatine kinase.MB/Creatine kinase.total [Pure catalytic fraction] in Serum or Plasma by Electrophoresis | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | |||||||||
1.000.380 | Cardiac Tests | CKMB % | 49136-5 | Creatine kinase.MB/Creatine kinase.total | Ratio | Pt | Ser/Plas | Qn | Creatine kinase.MB/Creatine kinase.total [Ratio] in Serum or Plasma | X | ACTIVE | 100% | Active | New item (PCM) | 102,00 | ||||||||||
1.000.407 | Cardiac Tests | BNP | 30934-4 | Natriuretic peptide.B | MCnc | Pt | Ser/Plas | Qn | Natriuretic peptide B [Mass/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.408 | Cardiac Tests | BNP | 47092-2 | Natriuretic peptide.B | SCnc | Pt | Ser/Plas | Qn | Natriuretic peptide B [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.406 | Cardiac Tests | BNP Blood | 42637-9 | Natriuretic peptide.B | MCnc | Pt | Bld | Qn | Natriuretic peptide B [Mass/volume] in Blood | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.410 | Cardiac Tests | Pro BNP | 33762-6 | Natriuretic peptide.B prohormone N-Terminal | MCnc | Pt | Ser/Plas | Qn | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.412 | Cardiac Tests | Pro BNP | 33763-4 | Natriuretic peptide.B prohormone N-Terminal | SCnc | Pt | Ser/Plas | Qn | Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.409 | Cardiac Tests | Pro BNP Blood by Immunoassay | 71425-3 | Natriuretic peptide.B prohormone N-Terminal | MCnc | Pt | Bld | Qn | IA | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Blood by Immunoassay | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.411 | Cardiac Tests | Pro BNP by Immunoassay | 83107-3 | Natriuretic peptide.B prohormone N-Terminal | MCnc | Pt | Ser/Plas | Qn | IA | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma by Immunoassay | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.413 | Cardiac Tests | Pro BNP by Immunoassay | 83108-1 | Natriuretic peptide.B prohormone N-Terminal | SCnc | Pt | Ser/Plas | Qn | IA | Natriuretic peptide.B prohormone N-Terminal [Moles/volume] in Serum or Plasma by Immunoassay | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.395 | Cardiac Tests | Troponin I | 10839-9 | Troponin I.cardiac | MCnc | Pt | Ser/Plas | Qn | Troponin I.cardiac [Mass/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.396 | Cardiac Tests | Troponin I | 49563-0 | Troponin I.cardiac | MCnc | Pt | Ser/Plas | Qn | Detection limit <= 0.01 ng/mL | Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.392 | Cardiac Tests | Troponin I (Discouraged) | 16255-2 | Troponin I.cardiac | ACnc | Pt | Ser/Plas | Qn | Troponin I.cardiac [Units/volume] in Serum or Plasma | DISCOURAGED | 100% | Active | 101,00 | 1.01 | |||||||||||
1.000.394 | Cardiac Tests | Troponin I Blood | 42757-5 | Troponin I.cardiac | MCnc | Pt | Bld | Qn | Troponin I.cardiac [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.393 | Cardiac Tests | Troponin I High Sensitivity | 89578-9 | Troponin I.cardiac | Imp | Pt | Ser/Plas | Ord | High sensitivity | Troponin I.cardiac [Interpretation] in Serum or Plasma Qualitative by High sensitivity method | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.397 | Cardiac Tests | Troponin I High Sensitivity | 89579-7 | Troponin I.cardiac | MCnc | Pt | Ser/Plas | Qn | High sensitivity | Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||
1.000.398 | Cardiac Tests | Troponin I Rapid Immunoassay | 76399-5 | Troponin I.cardiac | PrThr | Pt | Ser/Plas/Bld | Ord | IA.rapid | Troponin I.cardiac [Presence] in Serum, Plasma or Blood by Rapid immunoassay | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.402 | Cardiac Tests | Troponin T | 6598-7 | Troponin T.cardiac | MCnc | Pt | Ser/Plas | Qn | Troponin T.cardiac [Mass/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.400 | Cardiac Tests | Troponin T Blood | 48425-3 | Troponin T.cardiac | MCnc | Pt | Bld | Qn | Troponin T.cardiac [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.403 | Cardiac Tests | Troponin T High Sensitivity | 67151-1 | Troponin T.cardiac | MCnc | Pt | Ser/Plas | Qn | High sensitivity | Troponin T.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.405 | Cardiac Tests | Troponin T Qual | 33204-9 | Troponin T.cardiac | PrThr | Pt | Ser/Plas | Ord | Troponin T.cardiac [Presence] in Serum or Plasma | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.404 | Cardiac Tests | Troponin T Qual Blood | 48426-1 | Troponin T.cardiac | PrThr | Pt | Bld | Ord | Troponin T.cardiac [Presence] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.399 | Cardiac Tests | Troponin T Qual High Sensitivity | 89575-5 | Troponin T.cardiac | Imp | Pt | Ser/Plas | Ord | High sensitivity | Troponin T.cardiac [Interpretation] in Serum or Plasma Qualitative by High sensitivity method | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.401 | Cardiac Tests | Troponin T Venous | 6597-9 | Troponin T.cardiac | MCnc | Pt | BldV | Qn | Troponin T.cardiac [Mass/volume] in Venous blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.420 | Inflammatory Markers | CRP | 76485-2 | C reactive protein | SCnc | Pt | Ser/Plas | Qn | C reactive protein [Moles/volume] in Serum or Plasma | X | ACTIVE | 83% | Inactive | Item Inactivated. Updated Result Name and Category (PCM). | 101,00 | 1.02 | |||||||||
1.000.362 | Other Blood Chemistry Tests | CK | 2157-6 | Creatine kinase | CCnc | Pt | Ser/Plas | Qn | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.363 | Other Blood Chemistry Tests | CK (Discouraged) | 50756-6 | Creatine kinase | MCnc | Pt | Bld | Qn | Creatine kinase [Mass/volume] in Blood | DISCOURAGED | 100% | Active | 101,00 | 1.01 | |||||||||||
1.000.027 | Other Blood Chemistry Tests | Potassium (K) | 2823-3 | Potassium | SCnc | Pt | Ser/Plas | Qn | Potassium [Moles/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.026 | Other Blood Chemistry Tests | Potassium (K) (Discouraged) | 22760-3 | Potassium | MCnc | Pt | Ser/Plas | Qn | Potassium [Mass/volume] in Serum or Plasma | DISCOURAGED | 100% | Active | 101,00 | 1.01 | |||||||||||
1.000.037 | Other Blood Chemistry Tests | Potassium (K) Arterial | 32713-0 | Potassium | SCnc | Pt | BldA | Qn | Potassium [Moles/volume] in Arterial blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.035 | Other Blood Chemistry Tests | Potassium (K) Blood | 75940-7 | Potassium | MCnc | Pt | Bld | Qn | Potassium [Mass/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.036 | Other Blood Chemistry Tests | Potassium (K) Blood | 6298-4 | Potassium | SCnc | Pt | Bld | Qn | Potassium [Moles/volume] in Blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.038 | Other Blood Chemistry Tests | Potassium (K) Capillary | 39790-1 | Potassium | SCnc | Pt | BldC | Qn | Potassium [Moles/volume] in Capillary blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.039 | Other Blood Chemistry Tests | Potassium (K) Mixed Venous | 41656-0 | Potassium | SCnc | Pt | BldMV | Qn | Potassium [Moles/volume] in Mixed venous blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.028 | Other Blood Chemistry Tests | Potassium (K) Serum, Plasma or Blood | 77142-8 | Potassium | SCnc | Pt | Ser/Plas/Bld | Qn | Potassium [Moles/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.040 | Other Blood Chemistry Tests | Potassium (K) Venous | 39789-3 | Potassium | SCnc | Pt | BldV | Qn | Potassium [Moles/volume] in Venous blood | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.031 | Other Blood Chemistry Tests | Potassium (K) 2nd Specimen | 12812-4 | Potassium^2nd specimen | SCnc | Pt | Ser/Plas | Qn | Potassium [Moles/volume] in Serum or Plasma --2nd specimen | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.032 | Other Blood Chemistry Tests | Potassium (K) 3rd Specimen | 12813-2 | Potassium^3rd specimen | SCnc | Pt | Ser/Plas | Qn | Potassium [Moles/volume] in Serum or Plasma --3rd specimen | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.033 | Other Blood Chemistry Tests | Potassium (K) Post Dialysis | 29349-8 | Potassium^post dialysis | SCnc | Pt | Ser/Plas | Qn | Potassium [Moles/volume] in Serum or Plasma --post dialysis | X | ACTIVE | 100% | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
1.000.034 | Other Blood Chemistry Tests | Potassium (K) Pre Dialysis | 51618-7 | Potassium^pre dialysis | SCnc | Pt | Ser/Plas | Qn | Potassium [Moles/volume] in Serum or Plasma --pre dialysis | X | ACTIVE | 100% | Active | 101,00 | 1.01 | ||||||||||
1.000.014 | Other Blood Chemistry Tests | Sodium (Na) | 2951-2 | Sodium | SCnc | Pt | Ser/Plas | Qn | Sodium [Moles/volume] in Serum or Plasma | X | X | ACTIVE | 100% | Active | 101,00 | 1.01 | |||||||||
1.000.022 | Other Blood Chemistry Tests | Sodium (Na) Arterial | 32717-1 | Sodium | SCnc | Pt | BldA | Qn | Sodium [Moles/volume] in Arterial blood | X | ACTIVE | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.021 | Other Blood Chemistry Tests | Sodium (Na) Blood | 2947-0 | Sodium | SCnc | Pt | Bld | Qn | Sodium [Moles/volume] in Blood | X | ACTIVE | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.023 | Other Blood Chemistry Tests | Sodium (Na) Capillary | 39792-7 | Sodium | SCnc | Pt | BldC | Qn | Sodium [Moles/volume] in Capillary blood | X | ACTIVE | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.016 | Other Blood Chemistry Tests | Sodium (Na) Max during Study | 44783-9 | Sodium | SCnc | Stdy^max | Ser/Plas | Qn | Sodium [Moles/volume] (Maximum value during study) in Serum or Plasma | X | ACTIVE | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.024 | Other Blood Chemistry Tests | Sodium (Na) Mixed Venous | 41657-8 | Sodium | SCnc | Pt | BldMV | Qn | Sodium [Moles/volume] in Mixed venous blood | X | ACTIVE | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.015 | Other Blood Chemistry Tests | Sodium (Na) Serum, Plasma or Blood | 77139-4 | Sodium | SCnc | Pt | Ser/Plas/Bld | Qn | Sodium [Moles/volume] in Serum, Plasma or Blood | ACTIVE | Use only for a specific International laboratory system. US use discouraged. | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.025 | Other Blood Chemistry Tests | Sodium (Na) Venous | 39791-9 | Sodium | SCnc | Pt | BldV | Qn | Sodium [Moles/volume] in Venous blood | X | ACTIVE | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.019 | Other Blood Chemistry Tests | Sodium (Na) Corrected for Glucose | 51419-0 | Sodium^^corrected for glucose | SCnc | Pt | Ser/Plas | Qn | Sodium [Moles/volume] corrected for glucose in Serum or Plasma | X | ACTIVE | 67% | Active | 101,00 | 1.01 | ||||||||||
1.000.020 | Other Blood Chemistry Tests | Sodium (Na) Post Dialysis | 74688-3 | Sodium^post dialysis | SCnc | Pt | Ser/Plas | Qn | Sodium [Moles/volume] in Serum or Plasma --post dialysis | X | ACTIVE | 67% | Inactive | Item Inactivated | 101,00 | 1.02 | |||||||||
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Lab Primary Key | Clinical Category | Result Name | LOINC Code | LOINC Component | LOINC Property | LOINC Time | LOINC System | LOINC Scale | LOINC Method | LOINC Long Name | Common US Use | Common Intl Use | Also Consider | LOINC Status | External Comments | PCM Status | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
Medications
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Med Primary Key | Category | RxNorm Subclass | Medication | RxNorm Code | Term Type | Exclude Routes | NCI Code | International Use | External Comments | % Consensus Agreement | PCM Status | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.001 | Coronary Artery Disease | Medications | RxNorm | 01/12/2019 | 1.001.214 | Anti-Arrhythmics, Class Ia | Anti-Arrhythmics, Class Ia | procainamide | 8700 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | ||||
1.001.213 | Anti-Arrhythmics, Class Ia | Anti-Arrhythmics, Class Ia | quinidine | 9068 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.216 | Anti-Arrhythmics, Class Ib | Anti-Arrhythmics, Class Ib | lidocaine | 6387 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.215 | Anti-Arrhythmics, Class Ib | Anti-Arrhythmics, Class Ib | mexiletine | 6926 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.217 | Anti-Arrhythmics, Class Ic | Anti-Arrhythmics, Class Ic | flecainide | 4441 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.218 | Anti-Arrhythmics, Class Ic | Anti-Arrhythmics, Class Ic | propafenone | 8754 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.209 | Anti-Arrhythmics, Class III | Anti-Arrhythmics, Class III | amiodarone | 703 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.210 | Anti-Arrhythmics, Class III | Anti-Arrhythmics, Class III | dofetilide | 49247 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.211 | Anti-Arrhythmics, Class III | Anti-Arrhythmics, Class III | dronedarone | 233698 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.212 | Anti-Arrhythmics, Class III | Anti-Arrhythmics, Class III | ibutilide | 41289 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.017.434 | Anti-Hyperlipidemics | Angiopoietin-like 3 Protein (ANGPTL3) Inhibitors | evinacumab | 2478335 | IN | PCM Team Decision | Active | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.017.435 | Anti-Hyperlipidemics | Angiopoietin-like 3 Protein (ANGPTL3) Inhibitors | evinacumab-dgnb | 2478646 | PIN | PCM Team Decision | Inactive | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.001.096 | Anti-Hyperlipidemics | Antilipemic Agents | omega-3 acid ethyl esters (USP) | 484348 | IN | 67% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.095 | Anti-Hyperlipidemics | Antilipemic Agents and Vitamin D and Analogues | cholecalciferol / omega-3 acid ethyl esters (USP) | 1041795 | MIN | 67% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.084 | Anti-Hyperlipidemics | Bile Acid Sequestrants | cholestyramine resin | 2447 | IN | 67% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.431 | Anti-Hyperlipidemics | Bile Acid Sequestrants | colesevelam | 141626 | IN | 60% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.432 | Anti-Hyperlipidemics | Bile Acid Sequestrants | colestipol | 2685 | IN | 67% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.093 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | atorvastatin / ezetimibe | 1422085 | MIN | 100% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.094 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | ezetimibe / simvastatin | 484211 | MIN | 100% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.078 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | lovastatin / niacin | 352387 | MIN | 100% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.079 | Anti-Hyperlipidemics | Combinations of Various Lipid Modifying Agents | niacin / simvastatin | 803516 | MIN | 100% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.087 | Anti-Hyperlipidemics | Fibrates | choline fenofibrate | 1433887 | IN | 50% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.088 | Anti-Hyperlipidemics | Fibrates | fenofibrate | 8703 | IN | 83% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.091 | Anti-Hyperlipidemics | Fibrates | gemfibrozil | 4719 | IN | 83% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.433 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | atorvastatin | 83367 | IN | 100% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.434 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | fluvastatin | 41127 | IN | 100% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.073 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | lovastatin | 6472 | IN | 100% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.435 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | pitavastatin | 861634 | IN | 100% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.436 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | pravastatin | 42463 | IN | 100% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.437 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | rosuvastatin | 301542 | IN | 100% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.077 | Anti-Hyperlipidemics | HMG CoA Reductase Inhibitors | simvastatin | 36567 | IN | 100% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.092 | Anti-Hyperlipidemics | Nicotinic Acid and Derivatives | niacin | 7393 | IN | 83% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.010.933 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | bempedoic acid | 2283403 | IN | PCM Team Decision | Inactive | Entry Inactivated | 102,00 | 1.02.2 | |||||||||
1.017.455 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | bempedoic acid | 2282403 | IN | PCM Team Decision | Active | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.010.934 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | bempedoic acid / ezetimibe | 2283229 | MIN | PCM Team Decision | Active | Fields Updated (Medication,PCM Status,% Consensus Agreement) | 102,00 | 1.02.2 | |||||||||
1.001.082 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | ezetimibe | 341248 | IN | 83% | Active | Fields Updated (PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.439 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | lomitapide | 1364479 | IN | 50% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.442 | Anti-Hyperlipidemics | Other Lipid Modifying Agents | probucol | 8699 | IN | X | PCM Team Decision | Active | Fields Updated (International Use,PCM Status,% Consensus Agreement) | 102,00 | 1.02.2 | ||||||||
1.001.080 | Anti-Hyperlipidemics | Proprotein Convertase Subtilisin / Kexin Type 9 (PCSK9) Inhibitors | alirocumab | 1659152 | IN | 83% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.081 | Anti-Hyperlipidemics | Proprotein Convertase Subtilisin / Kexin Type 9 (PCSK9) Inhibitors | evolocumab | 1665684 | IN | 83% | Active | Fields Updated (RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.003.208 | Anti-Hypertensives | ACE Inhibitors, Plain | benazepril | 18867 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.102 | Anti-Hypertensives | ACE Inhibitors, Plain | captopril | 1998 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.004.449 | Anti-Hypertensives | ACE Inhibitors, Plain | enalapril | 3827 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.104 | Anti-Hypertensives | ACE Inhibitors, Plain | enalaprilat | 3829 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.004.450 | Anti-Hypertensives | ACE Inhibitors, Plain | fosinopril | 50166 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.106 | Anti-Hypertensives | ACE Inhibitors, Plain | lisinopril | 29046 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.003.209 | Anti-Hypertensives | ACE Inhibitors, Plain | moexipril | 30131 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.004.451 | Anti-Hypertensives | ACE Inhibitors, Plain | perindopril | 54552 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.003.210 | Anti-Hypertensives | ACE Inhibitors, Plain | quinapril | 35208 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.110 | Anti-Hypertensives | ACE Inhibitors, Plain | ramipril | 35296 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.111 | Anti-Hypertensives | ACE Inhibitors, Plain | trandolapril | 38454 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.128 | Anti-Hypertensives | Adrenergic and Dopaminergic Agents | fenoldopam | 24853 | IN | 83% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.127 | Anti-Hypertensives | Aldosterone Antagonists | eplerenone | 298869 | IN | 83% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.123 | Anti-Hypertensives | Alpha Adrenoreceptor Antagonists | doxazosin | 49276 | IN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.003.456 | Anti-Hypertensives | Alpha Adrenoreceptor Antagonists | prazosin | 8629 | IN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.003.457 | Anti-Hypertensives | Alpha Adrenoreceptor Antagonists | terazosin | 37798 | IN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.132 | Anti-Hypertensives | Alpha and Beta Blocking Agents | carvedilol | 20352 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.280 | Anti-Hypertensives | Alpha and Beta Blocking Agents | labetalol | 6185 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.223 | Anti-Hypertensives | Angiotensin II Antagonists, Other Combinations | sacubitril / valsartan | 1656339 | MIN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.004.444 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | azilsartan | 1091643 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.004.445 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | candesartan | 214354 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.004.446 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | eprosartan | 83515 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.115 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | irbesartan | 83818 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.004.447 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | losartan | 52175 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.004.448 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | olmesartan | 321064 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.118 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | telmisartan | 73494 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.119 | Anti-Hypertensives | Angiotensin II Receptor Blockers (ARBs), Plain | valsartan | 69749 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.148 | Anti-Hypertensives | Antihypertensive Combinations | aliskiren / amlodipine | 1009219 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.149 | Anti-Hypertensives | Antihypertensive Combinations | aliskiren / amlodipine / hydrochlorothiazide | 1050797 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.150 | Anti-Hypertensives | Antihypertensive Combinations | aliskiren / hydrochlorothiazide | 802519 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.151 | Anti-Hypertensives | Antihypertensive Combinations | aliskiren / valsartan | 900937 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.152 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / benazepril | 214223 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.174 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / hydrochlorothiazide / olmesartan | 1008801 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.175 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / perindopril | 1033889 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.178 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / telmisartan | 901212 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.153 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine / valsartan | 729455 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.154 | Anti-Hypertensives | Antihypertensive Combinations | amlodipine/ olmesartan | 1009015 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,Medication,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.156 | Anti-Hypertensives | Antihypertensive Combinations | atenolol / chlorthalidone | 151195 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.157 | Anti-Hypertensives | Antihypertensive Combinations | azilsartan / chlorthalidone | 1235143 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.158 | Anti-Hypertensives | Antihypertensive Combinations | benazepril / hydrochlorothiazide | 214287 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.172 | Anti-Hypertensives | Antihypertensive Combinations | bendroflumethiazide / nadolol | 214288 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.159 | Anti-Hypertensives | Antihypertensive Combinations | bisoprolol / hydrochlorothiazide | 214317 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.160 | Anti-Hypertensives | Antihypertensive Combinations | candesartan / hydrochlorothiazide | 284628 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.161 | Anti-Hypertensives | Antihypertensive Combinations | captopril / hydrochlorothiazide | 214357 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.162 | Anti-Hypertensives | Antihypertensive Combinations | chlorthalidone / clonidine | 214418 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.155 | Anti-Hypertensives | Antihypertensive Combinations | enalapril / diltiazem | 214507 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,Medication,RxNorm Code,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.163 | Anti-Hypertensives | Antihypertensive Combinations | enalapril / hydrochlorothiazide | 214536 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.164 | Anti-Hypertensives | Antihypertensive Combinations | eprosartan / hydrochlorothiazide | 352375 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.165 | Anti-Hypertensives | Antihypertensive Combinations | fosinopril / hydrochlorothiazide | 261415 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.166 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / irbesartan | 214617 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.167 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / lisinopril | 214618 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.168 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / losartan | 214619 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.169 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / methyldopa | 214620 | MIN | 67% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.170 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / metoprolol | 214621 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.171 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / moexipril | 214622 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.173 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / olmesartan | 817496 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.176 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / propranolol | 214623 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.177 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / quinapril | 261417 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.179 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / telmisartan | 284636 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.181 | Anti-Hypertensives | Antihypertensive Combinations | hydrochlorothiazide / valsartan | 214626 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.180 | Anti-Hypertensives | Antihypertensive Combinations | trandolapril / verapamil | 214866 | MIN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.287 | Anti-Hypertensives | Arteriolar Smooth Muscle, Agents Acting On | hydralazine | 5470 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.130 | Anti-Hypertensives | Arteriolar Smooth Muscle, Agents Acting On | minoxidil | 6984 | IN | 83% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.131 | Anti-Hypertensives | Arteriolar Smooth Muscle, Agents Acting On | sodium nitroprusside | 9895 | PIN | 83% | Inactive | Entry Inactivated | 101,00 | 1.02.2 | |||||||||
1.001.276 | Anti-Hypertensives | Beta Blocking Agents | acebutolol | 149 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.141 | Anti-Hypertensives | Beta Blocking Agents | atenolol | 1202 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.277 | Anti-Hypertensives | Beta Blocking Agents | betaxolol | 1520 | IN | 67% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.278 | Anti-Hypertensives | Beta Blocking Agents | bisoprolol | 19484 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.279 | Anti-Hypertensives | Beta Blocking Agents | esmolol | 49737 | IN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.281 | Anti-Hypertensives | Beta Blocking Agents | metoprolol | 6918 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.145 | Anti-Hypertensives | Beta Blocking Agents | metoprolol succinate | 221124 | PIN | 100% | Inactive | Entry Inactivated | 101,00 | 1.02.2 | |||||||||
1.001.146 | Anti-Hypertensives | Beta Blocking Agents | metoprolol tartrate | 203191 | PIN | 100% | Inactive | Entry Inactivated | 101,00 | 1.02.2 | |||||||||
1.001.135 | Anti-Hypertensives | Beta Blocking Agents | nadolol | 7226 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.282 | Anti-Hypertensives | Beta Blocking Agents | nebivolol | 31555 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.283 | Anti-Hypertensives | Beta Blocking Agents | penbutolol | 7973 | IN | PCM Team Decision | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.136 | Anti-Hypertensives | Beta Blocking Agents | pindolol | 8332 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.284 | Anti-Hypertensives | Beta Blocking Agents | propranolol | 8787 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.285 | Anti-Hypertensives | Beta Blocking Agents | sotalol | 9947 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.286 | Anti-Hypertensives | Beta Blocking Agents | timolol | 10600 | IN | 67% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.221 | Anti-Hypertensives | Calcium Channel Blockers | amlodipine | 17767 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.219 | Anti-Hypertensives | Calcium Channel Blockers | diltiazem | 3443 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.220 | Anti-Hypertensives | Calcium Channel Blockers | verapamil | 11170 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.288 | Anti-Hypertensives | Imidazoline Receptor Agonists | clonidine | 2599 | IN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.003.455 | Anti-Hypertensives | Imidazoline Receptor Agonists | guanfacine | 40114 | IN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.122 | Anti-Hypertensives | Rauwolfia Alkaloids | reserpine | 9260 | IN | 50% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.126 | Anti-Hypertensives | Renin Inhibitors | aliskiren | 325646 | IN | PCM Team Decision | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.197 | Anti-Thrombotic Agents | Direct Factor Xa Inhibitors | apixaban | 1364430 | IN | 83% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.198 | Anti-Thrombotic Agents | Direct Factor Xa Inhibitors | edoxaban | 1599538 | IN | 83% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.199 | Anti-Thrombotic Agents | Direct Factor Xa Inhibitors | rivaroxaban | 1114195 | IN | 83% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.007.649 | Anti-Thrombotic Agents | Direct Thrombin Inhibitirs | dabigatran etexilate | 1037042 | IN | 100% | Active | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.001.200 | Anti-Thrombotic Agents | Direct Thrombin Inhibitors | argatroban | 15202 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.201 | Anti-Thrombotic Agents | Direct Thrombin Inhibitors | bivalirudin | 60819 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.202 | Anti-Thrombotic Agents | Direct Thrombin Inhibitors | dabigatran | 1546356 | IN | 100% | Inactive | Entry Inactivated | 101,00 | 1.02.2 | |||||||||
1.001.203 | Anti-Thrombotic Agents | Direct Thrombin Inhibitors | desirudin | 114934 | IN | 80% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.204 | Anti-Thrombotic Agents | Direct Thrombin Inhibitors | lepirudin | 237057 | IN | 80% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.205 | Anti-Thrombotic Agents | Heparin Group | dalteparin | 67109 | IN | 80% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.206 | Anti-Thrombotic Agents | Heparin Group | enoxaparin | 67108 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.074 | Anti-Thrombotic Agents | Heparin Group | heparin | 5224 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.207 | Anti-Thrombotic Agents | Heparin Group | heparin, porcine | 235473 | PIN | 100% | Inactive | Entry Inactivated | 101,00 | 1.02.2 | |||||||||
1.001.208 | Anti-Thrombotic Agents | Other Antithrombotic Agents | fondaparinux | 321208 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.182 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | abciximab | 83929 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.184 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | aspirin | 1191 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.185 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | aspirin / dipyridamole | 226716 | MIN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.186 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | cangrelor | 1656052 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.187 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | cilostazol | 21107 | IN | 83% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.188 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | clopidogrel | 32968 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.189 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | dipyridamole | 3521 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.190 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | eptifibatide | 75635 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.191 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | prasugrel | 613391 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.192 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | ticagrelor | 1116632 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.193 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | ticlopidine | 10594 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.194 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | tirofiban | 73137 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.195 | Anti-Thrombotic Agents | Platelet Aggregation Inhibitors, Excluding Heparin | vorapaxar | 1537034 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.183 | Anti-Thrombotic Agents | Platelet-reducing Agent | anagrelide | 596724 | IN | 60% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.196 | Anti-Thrombotic Agents | Vitamin K Antagonists | warfarin | 11289 | IN | 83% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.222 | Cardiac Glycosides | Digitalis Glycosides | digoxin | 3407 | IN | 100% | Active | Fields Updated (Category,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.006.169 | Cardiovascular Agents | Vasodilators | nitroprusside | 7476 | IN | 83% | Active | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.001.100 | Other Cardiac Preparations | Other Cardiac Preparations | ranolazine | 35829 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.006.185 | Vasodilators Used in Cardiac Disease | Organic Nitrates | Isosorbide | 6057 | IN | 100% | Active | New Entry (PCM) | 1.022,00 | 1.02.2 | |||||||||
1.001.097 | Vasodilators Used in Cardiac Disease | Organic Nitrates | Isosorbide dinitrate | 6058 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
1.001.098 | Vasodilators Used in Cardiac Disease | Organic Nitrates | Isosorbide mononitrate | 28004 | PIN | 100% | Inactive | Entry Inactivated | 101,00 | 1.02.2 | |||||||||
1.001.099 | Vasodilators Used in Cardiac Disease | Organic Nitrates | nitroglycerin | 4917 | IN | 100% | Active | Fields Updated (Category,RxNorm Subclass,PCM Status,% Consensus Agreement) | 101,00 | 1.02.2 | |||||||||
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Med Primary Key | Category | RxNorm Subclass | Medication | RxNorm Code | Term Type | Exclude Routes | NCI Code | International Use | External Comments | % Consensus Agreement | PCM Status | Release Change Comments | PCM Version First Released | PCM Version Last Updated |
Definition
All Problems on this web site are defined as a set of SNOMED CT codes. To view a term and its descendants, go to the International SNOMED site. Then, if in the United States, see LOCAL EXTENSIONS and select the US Browser. Enter the term number or name.
Problems with the following codes (and their descendants) will trigger the map according to the logic listed.
Associated Problem ID | Associated Problem Name | Data Domain | Coding System | Coding System Version | Row | Include Descendants? | Clinical Name | SNOMED CT Fully Specified Name (FSN) | SNOMED CT | Logic |
---|---|---|---|---|---|---|---|---|---|---|
1.001 | Coronary Artery Disease | Definition | SNOMED CT | 01/09/2020 | 1 | Y | Ischemic heart disease | Ischemic heart disease (disorder) | 414545008 | (1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14) AND NOT (15 OR 16) |
2 | Y | Coronary arteriosclerosis | Coronary arteriosclerosis (disorder) | 53741008 | ||||||
3 | Y | Coronary artery atheroma | Coronary artery atheroma (disorder) | 67682002 | ||||||
4 | Y | Coronary artery stenosis | Coronary artery stenosis (disorder) | 233970002 | ||||||
5 | Y | Coronary artery thrombosis | Coronary artery thrombosis (disorder) | 398274000 | ||||||
6 | Y | Coronary artery embolism | Coronary artery embolism (disorder) | 29899005 | ||||||
7 | Y | Coronary occlusion | Coronary occlusion (disorder) | 63739005 | ||||||
8 | Y | Calcification of coronary artery | Calcification of coronary artery (disorder) | 445512009 | ||||||
9 | Y | Fracture of stent of coronary artery | Fracture of stent of coronary artery (disorder) | 442298000 | ||||||
10 | Y | Furcation lesion of coronary artery | Furcation lesion of coronary artery (disorder) | 440444007 | ||||||
11 | Y | Mechanical complication of coronary bypass | Mechanical complication of coronary bypass (disorder) | 213037002 | ||||||
12 | Y | History of percutaneous coronary intervention | History of percutaneous coronary intervention (situation) | 405741001 | ||||||
13 | Y | History of coronary artery bypass grafting | History of coronary artery bypass grafting (situation) | 399261000 | ||||||
14 | Y | History of myocardial infarction | History of myocardial infarction (situation) | 399211009 | ||||||
15 | Y | Silent coronary vasospastic disease | Silent coronary vasospastic disease (disorder) | 703214003 | ||||||
16 | Y | Transient myocardial ischemia of newborn | Transient myocardial ischemia of newborn (disorder) | 276517000 |
Copyright © 2016-2020. Board of Regents of the University of Wisconsin System. All rights reserved.